Journal of Epidemiology and Public Health
ISSN: 3065-9078 | DOI: 10.64030/3065-9078
Racheal Taiwo Bakare, Konstantin Koshechkin, Maryam Tariq and Qanita Saleha
This study examines the impact of advanced digital technologies on the pharmaceutical industry, focusing on innovations such as artificial intelligence, blockchain, cloud computing, three-dimensional printing, and the Internet of Things. These technologies are transforming drug development, supply chain management, regulatory compliance, and patient services by enhancing efficiency, transparency, and safety, which fosters a more patient-centered healthcare system. Despite these benefits, challenges remain, including cybersecurity threats, limited system compatibility, uneven technology adoption in smaller or remote pharmacies, outdated infrastructure, and high costs. To address these issues, the study explores solutions like remote pharmacy services, telemedicine, and artificial intelligence-powered tools to increase care access for underserved populations. Collaborative digital platforms and cloud-based analytics are also highlighted for accelerating research and adapting to changing healthcare demands. The study finds that while artificial intelligence-driven diagnostics and predictive analytics offer great potential for personalized treatments and better health outcomes, their success depends on strong data management, stakeholder cooperation, and equitable access to technology. Carefully integrating these digital technologies can help the pharmaceutical sector provide safer, faster, and more accessible healthcare worldwide, turning challenges into growth opportunities.